PSA Vice President Professor Mark Naunton MPS[/caption]
Dr Louise Schaper at PSA25[/caption]
Early elixir: brompheniramine, a first-generation antihistamine
For over 70 years brompheniramine has been used to stifle sneezes … but not for everyone.
New Cochrane review highlights lack of evidence on medicine-taking ability and...
Interventions initiated at the hospital-community interface may be the best way to influence multiple medicine adherence in older adults, a new Cochrane review has found.
TGA approves Pfizer booster for teens
Pfizer’s Comirnaty COVID-19 vaccine has been provisionally approved by the Therapeutic Goods Administration (TGA) for use as a booster in those aged 16–17 years.
What’s in the DAA?
Two pharmacists share safety risks averted by using every DAA packing check as a mini-medicine review.
Weight loss management
Obesity is one of the most significant public health concerns worldwide. Almost 70% of Australians and 25% of children are overweight or obese.
Should cannabidiol be down-scheduled to S3?
The Therapeutic Goods Administration (TGA) has delivered an interim decision to down-schedule low dose cannabidiol.
